ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms

被引:0
|
作者
D. James Morré
Brandon Hostetler
David J. Taggart
Dorothy M. Morré
A. W. Musk
Bruce W. S. Robinson
Jenette Creaney
机构
[1] Purdue University Research Park,MorNuCo, Inc
[2] University of Western Australia,National Centre for Asbestos Related Disease
[3] University of Western Australia,School of Medicine and Pharmacology
[4] Sir Charles Gairdner Hospital,Department of Respiratory Medicine
[5] University of Western Australia,School of Population Health
来源
Clinical Proteomics | 2016年 / 13卷
关键词
Malignant mesothelioma; ENOX2; Early detection; ONCOblot tissue of origin cancer test; Serum analysis; Asbestos;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 5 条
  • [1] Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms
    D. James Morré
    Brandon Hostetler
    David J. Taggart
    Dorothy M. Morré
    A. W. Musk
    Bruce W. S. Robinson
    Jenette Creaney
    Clinical Proteomics, 2016, 13
  • [2] ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms
    Morre, D. James
    Hostetler, Brandon
    Taggart, David J.
    Morre, Dorothy M.
    Musk, A. W.
    Robinson, Bruce W. S.
    Creaney, Jenette
    CLINICAL PROTEOMICS, 2016, 13
  • [3] ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms (vol 13, 2, 2016)
    Morre, D. James
    Hostetler, Brandon
    Taggart, David J.
    Morre, Dorothy M.
    Musk, A. W.
    Robinson, Bruce W. S.
    Creaney, Jenette
    CLINICAL PROTEOMICS, 2016, 13
  • [4] Serum mesothelin for early detection of the asbestos-induced cancer malignant mesothelioma
    Creaney, Jenette
    Robinson, Bruce W. S.
    Segal, Amanda
    Musk, Arthur W.
    de Klerk, Nick
    Pass, Harvey I.
    Skates, Steven J.
    CANCER BIOMARKERS, 2008, 4 (03) : 169 - 170
  • [5] Serum Mesothelin for Early Detection of Asbestos-Induced Cancer Malignant Mesothelioma
    Creaney, Jenette
    Olsen, Nola J.
    Brims, Fraser
    Dick, Ian M.
    Musk, Arthur W.
    de Klerk, Nicholas H.
    Skates, Steven J.
    Robinson, Bruce W. S.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (09) : 2238 - 2246